Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics

Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...
Drug Target Review

Preclinical takeaways from the World ADC Conference London

Explore the World ADC Conference highlights on antibody-drug conjugates and their impact on cancer therapy and clinical ...
EurekAlert!

Artificial intelligence revolutionizes anti-infective drug discovery: From target identification to lead optimization

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
GEN

Drug Discovery Innovation: Target Deconvolution and Tractability Assessment

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...